APA (7th ed.) Citation

Yao, S., Huang, Q., Zou, Y., Liu, T., Yang, Y., Huang, T., . . . Dong, X. (2025). The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-97160-7

Chicago Style (17th ed.) Citation

Yao, Siyang, Qiangsong Huang, Yan Zou, Tianqi Liu, Yongyu Yang, Tao Huang, Yuanquan Zhao, and Xiaofeng Dong. "The Efficacy and Safety of Thymosin Alpha-1 Combined with Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-97160-7.

MLA (9th ed.) Citation

Yao, Siyang, et al. "The Efficacy and Safety of Thymosin Alpha-1 Combined with Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-97160-7.